FROM 2007 to 2016, the US Food and Drug Administration (FDA) approved more new drugs and biologics first than its European and Swiss regulatory counterparts, according to a comparison in the European Journal of Clinical Pharmacology - CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Feb 18